Cargando…
CXCL5/NF-κB Pathway as a Therapeutic Target in Hepatocellular Carcinoma Treatment
BACKGROUND: Hepatocellular carcinoma (HCC) is a common malignant cancer worldwide. CXCL5 has a role in inhibiting cell viability and metastasis in many tumors. In the present study, we investigated the role of CXCL5 in HCC and explored the underlying mechanism. Material and Methods. RT-qPCR and west...
Autores principales: | Jia, Xingqing, Wei, Shuangqin, Xiong, Wujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184336/ https://www.ncbi.nlm.nih.gov/pubmed/34194499 http://dx.doi.org/10.1155/2021/9919494 |
Ejemplares similares
-
The NFκB pathway: a therapeutic target in glioblastoma
por: Nogueira, Lorena, et al.
Publicado: (2011) -
Paeonol-mediated apoptosis of hepatocellular carcinoma cells by NF-κB pathway
por: Li, Qiang, et al.
Publicado: (2019) -
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
por: Chung, Po Yee, et al.
Publicado: (2018) -
Minichromosome maintenance 3 promotes hepatocellular carcinoma radioresistance by activating the NF-κB pathway
por: Meng, Wei, et al.
Publicado: (2019) -
IDO1 facilitates esophageal carcinoma progression by driving the direct binding of NF-κB and CXCL10
por: Yao, Wenjian, et al.
Publicado: (2023)